IsoPlexis Proteomic Product Suite for Cancer Immunology

Learn how IsoPlexis’ Functional Proteomics reveals unique secretomic signatures and insights into Cancer Immunology.

Your data is secure

We keep your personal information safe and do not share it with any third parties. By submitting this form, you agree to receive communications from IsoPlexis and accept our Privacy Policy. You may unsubscribe at any time.

What's Inside

In this we discuss:

Understanding cancer cell communication to infer a strategy to inhibit tumor cell metastasis
Explloring an inhibitory mechanism of monocytes toward immune suppression in Follicular Lymphoma (FL)
Using mechanisms of immune persistence in solid tumor indications
Resolving tumor heterogeneity to reveal independent trajectories of drug tolerance
A Deeper Look

More about this

Overcoming Challenges in Cancer Immunology

Cancer cells in the tumor microenvironment secrete cytokines that interact with other cells, such as immune cells, facilitating intracellular communications and jointly moderating pathophysiological processes, including cancer-induced angiogenesis and metastasis.

Heterogeneity in cytokine production and aberrant cytokine signatures can create challenges in cancer immunotherapy.

Download this App Note to learn how IsoPlexis helps you overcome these challenges by functionally defining each cell type to inform more effective therapies.

awards-bar-3-wide-color-right
awards-bar-4-wide-color-left
Get the